Skip Navigation
Skip to contents
ABOUT
Aims and scope
About the journal
Editorial board
Management team
Best practice
Metrics
Contact us
BROWSE ARTICLES
Current issue
All issues
Ahead-of print
Article by category
Article by topic
Article by Category
2022-2023
Special thematic issues
Guidelines in DMJ
Fact sheets in DMJ
COVID-19 in DMJ
Best paper of the year
Most view
Most cited
Funded articles
Diabetes Metab J Search
Author index
EDITORIAL POLICY
Research and publication ethics
Peer review policy
Copyright and open access policy
Article sharing (author self-archiving) policy
Archiving policy
Data sharing policy
Preprint policy
Advertising policy
FOR CONTRIBUTORS
For Authors
Instructions to authors
Article processing charge
e-submission
For Reviewers
Instructions for reviewers
How to become a reviewer
Best reviewers
For Readers
Readership
Subscription
Permission guidelines
KDA
Contact us
E-SUBMISSION
SEARCH
Search
Advanced Search
mobile menu button
About
Aims and scope
About the journal
Editorial board
Management team
Best practice
Metrics
Contact us
Browse articles
Current issue
All issues
Ahead-of print
Article by category
Article by topic
Article by Category
2022-2023
Special thematic issues
Guidelines in DMJ
Fact sheets in DMJ
COVID-19 in DMJ
Best paper of the year
Most view
Most cited
Funded articles
Diabetes Metab J Search
Author index
Editorial policy
Research and publication ethics
Peer review policy
Copyright and open access policy
Article sharing (author self-archiving) policy
Archiving policy
Data sharing policy
Preprint policy
Advertising policy
For contributors
For Authors
Instructions to authors
Article processing charge
e-submission
For Reviewers
Instructions for reviewers
How to become a reviewer
Best reviewers
For Readers
Readership
Subscription
Permission guidelines
IMAGE VIEW
Current issue
Volume 47(6); November 2023
PREVIOUS
ALL ISSUES
Type 2 Diabetes Mellitus and Sarcopenia as Comorbid Chronic Diseases in Older Adults: Established and Emerging Treatments and Therapies
Jakub Mesinovic, Jackson J. Fyfe, Jason Talevski, Michael J. Wheeler, Gloria K.W. Leung, et al.
Diabetes Metab J. 2023;47(6):719-742.
Review
September 14, 2023
Pharmacological and Nonpharmacological Treatments for Painful Diabetic Peripheral Neuropathy
Han Na Jang, Tae Jung Oh
Diabetes Metab J. 2023;47(6):743-756.
Review
September 6, 2023
Immune-Checkpoint Inhibitors-Induced Type 1 Diabetes Mellitus: From Its Molecular Mechanisms to Clinical Practice
Yun Kyung Cho, Chang Hee Jung
Diabetes Metab J. 2023;47(6):757-766.
Review
July 24, 2023
Ensuring Heathy Lives with the Korea Disease Control and Prevention Agency: Partnership with the Korean Diabetes Association
Youngmee Jee
Diabetes Metab J. 2023;47(6):767-768.
Special Editorial
November 24, 2023
Navigating the Future of Diabetes Treatment with New Drugs: Focusing on the Possibilities and Prospects of Enavogliflozin
Sang Youl Rhee
Diabetes Metab J. 2023;47(6):769-770.
Editorial
November 24, 2023
Effects Of Exercise Training And Chlorogenic Acid Supplementation On Hepatic Lipid Metabolism In Prediabetes Mice
Samaneh Shirkhani, Sayyed Mohammad Marandi, Mohammad Hossein Nasr-Esfahani, Seung Kyum Kim
Diabetes Metab J. 2023;47(6):771-783.
Original Article
September 8, 2023
Altered Metabolic Phenotypes and Hypothalamic Neuronal Activity Triggered by Sodium-Glucose Cotransporter 2 Inhibition
Ho Gyun Lee, Il Hyeon Jung, Byong Seo Park, Hye Rim Yang, Kwang Kon Kim, et al.
Diabetes Metab J. 2023;47(6):784-795.
Original Article
August 23, 2023
Efficacy and Safety of Enavogliflozin versus Dapagliflozin as Add-on to Metformin in Patients with Type 2 Diabetes Mellitus: A 24-Week, Double-Blind, Randomized Trial
Kyung Ah Han, Yong Hyun Kim, Doo Man Kim, Byung Wan Lee, Suk Chon, et al.
Diabetes Metab J. 2023;47(6):796-807.
Original Article
February 9, 2023
Efficacy and Safety of Evogliptin Add-on Therapy to Dapagliflozin/Metformin Combinations in Patients with Poorly Controlled Type 2 Diabetes Mellitus: A 24-Week Multicenter Randomized Placebo-Controlled Parallel-Design Phase-3 Trial with a 28-Week Extension
Jun Sung Moon, Il Rae Park, Hae Jin Kim, Choon Hee Chung, Kyu Chang Won, et al.
Diabetes Metab J. 2023;47(6):808-817.
Original Article
September 26, 2023
The Efficacy and Safety of Moderate-Intensity Rosuvastatin with Ezetimibe versus High-Intensity Rosuvastatin in High Atherosclerotic Cardiovascular Disease Risk Patients with Type 2 Diabetes Mellitus: A Randomized, Multicenter, Open, Parallel, Phase 4 Study
Jun Sung Moon, Il Rae Park, Sang Soo Kim, Hye Soon Kim, Nam Hoon Kim, et al.
Diabetes Metab J. 2023;47(6):818-825.
Original Article
November 24, 2023
pasue
play
Review
Sep 14, 2023
Type 2 Diabetes Mellitus and Sarcopenia as Comorbid Chronic Diseases in Older Adults: Established and Emerging Treatments and Therapies
Jakub Mesinovic, Jackson J. Fyfe, Jason Talevski, et al.
Diabetes Metab J. 2023;47(6):719-742.
Review
Sep 6, 2023
Pharmacological and Nonpharmacological Treatments for Painful Diabetic Peripheral Neuropathy
Han Na Jang, Tae Jung Oh
Diabetes Metab J. 2023;47(6):743-756.
Review
Jul 24, 2023
Immune-Checkpoint Inhibitors-Induced Type 1 Diabetes Mellitus: From Its Molecular Mechanisms to Clinical Practice
Yun Kyung Cho, Chang Hee Jung
Diabetes Metab J. 2023;47(6):757-766.
Special Editorial
Nov 24, 2023
Ensuring Heathy Lives with the Korea Disease Control and Prevention Agency: Partnership with the Korean Diabetes Association
Youngmee Jee
Diabetes Metab J. 2023;47(6):767-768.
Editorial
Nov 24, 2023
Navigating the Future of Diabetes Treatment with New Drugs: Focusing on the Possibilities and Prospects of Enavogliflozin
Sang Youl Rhee
Diabetes Metab J. 2023;47(6):769-770.
Original Article
Sep 8, 2023
Effects Of Exercise Training And Chlorogenic Acid Supplementation On Hepatic Lipid Metabolism In Prediabetes Mice
Samaneh Shirkhani, Sayyed Mohammad Marandi, Mohammad Hossein Nasr-Esfahani, et al.
Diabetes Metab J. 2023;47(6):771-783.
VIEW MORE
Ahead-of print
Extracellular Vimentin Alters Energy Metabolism And Induces Adipocyte Hypertrophy
Glucolipotoxicity Suppressed Autophagy and Insulin Contents in Human Islets, and Attenuation of PERK Activity Enhanced Them in an ATG7-Dependent Manner
VIEW MORE
Most cited
Diabetes Fact Sheets in Korea, 2020: An Appraisal of Current Status
150
2021 Clinical Practice Guidelines for Diabetes Mellitus in Korea
126
Insulin Resistance: From Mechanisms to Therapeutic Strategies
118
Treatment of Diabetic Kidney Disease: Current and Future
78
VIEW MORE
Diabetes & Metabolism Journal
Print ISSN: 2233-6079
Online ISSN: 2233-6087
Latest Issue:
Volume 47 Issue 6
Article by Category
2022-2023
E-Submission
Submit Your Manuscript
Special thematic issues
Best paper of the year
Sex Differences of Visceral Fat Area and Visceral-to-Subcutaneous Fat Ratio for the Risk of Incident Type 2 Diabetes Mellitus
Eun Hee Kim, Hong-Kyu Kim, Min Jung Lee, et al.
Efficacy and Safety of Self-Titration Algorithms of Insulin Glargine 300 units/mL in Individuals with Uncontrolled Type 2 Diabetes Mellitus (The Korean TITRATION Study): A Randomized Controlled Trial
Jae Hyun Bae, Chang Ho Ahn, Ye Seul Yang, et al.
Reproductive Life Span and Severe Hypoglycemia Risk in Postmenopausal Women with Type 2 Diabetes Mellitus
Soyeon Kang, Yong-Moon Park, Dong Jin Kwon, et al.
Serum Retinol-Binding Protein Levels Are Associated with Nonalcoholic Fatty Liver Disease in Chinese Patients with Type 2 Diabetes Mellitus: A Real-World Study
Zhi-Hui Zhang, Jiang-Feng Ke, Jun-Xi Lu, et al.
VIEW MORE
Recent Issues
v.47(6) 11 2023
v.47(5) 9 2023
v.47(4) 7 2023
v.47(3) 5 2023
v.47(2) 3 2023
v.47(1) 1 2023
v.46(6) 11 2022
v.46(5) 9 2022
v.46(4) 7 2022
v.46(3) 5 2022
v.46(2) 3 2022
v.46(1) 1 2022
VIEW MORE